BioMed Research International

BioMed Research International / 2015 / Article
Special Issue

Experimental Heart Failure Models and Their Pathophysiological Characterization

View this Special Issue

Research Article | Open Access

Volume 2015 |Article ID 893051 | 9 pages | https://doi.org/10.1155/2015/893051

Comparative Analysis of Methods to Induce Myocardial Infarction in a Closed-Chest Rabbit Model

Academic Editor: Bastian Schmack
Received25 Mar 2015
Accepted25 May 2015
Published04 Oct 2015

Abstract

Objective. To develop a rabbit model of closed-chest catheter-induced myocardial infarction. Background. Limitations of rodent and large animal models justify the search for clinically relevant alternatives. Methods. Microcatheterization of the heart was performed in 47 anesthetized 3-4 kg New Zealand rabbits to test five techniques of myocardial ischemia: free coils (), interlocking coils (), thrombogenic gelatin sponge (), balloon occlusion (), and alcohol injection (). In order to limit ventricular fibrillation, an antiarrhythmic protocol was implemented, with beta-blockers/amiodarone before and xylocaine infusion during the procedure. Clinical, angiographic, and echographic data were gathered. End points included demonstration of vessel occlusion (TIMI flow grades 0 and 1 on the angiogram), impairment of left ventricular function at 2 weeks after procedure (by echocardiography), and pathologically confirmed myocardial infarction. Results. The best arterial access was determined to be through the right carotid artery. The internal mammary guiding catheter 4-Fr was selected as the optimal device for selective intracoronary injection. Free coils deployed prematurely and tended to prolapse into the aorta. Interlocking coils did not deploy completely and failed to provide reliable results. Gelatin sponge was difficult to handle, adhered to the catheter, and could not be clearly visualized by fluoroscopy. Balloon occlusion yielded inconsistent results. Alcohol injection was the most efficient and reproducible method for inducing myocardial infarction (4 out of 6 animals), the extent of which could be fine-tuned by using a coaxial balloon catheter as a microcatheter (0.52 mm) to achieve a superselective injection of 0.2 mL of alcohol. This approach resulted in a 20% decrease in LVEF and infarcted myocardium was confirmed histologically. Conclusions. By following a stepwise approach, a minimally invasive, effective, and reproducible rabbit model of catheter-induced myocardial infarction has been developed which addresses the limitations of rodent experiments while avoiding the logistical and cost issues associated with large animal models.

1. Introduction

Heart failure (HF) is a major health and economic burden in developing countries and its prevalence is increasing [1, 2]. It is a complex, heterogeneous disorder that can result from primary cardiomyopathy or, more commonly, from myocardial infarction (MI), hypertension, or disorders of the valve [3, 4]. Because many HF cases are secondary to ischemic heart disease, animal models that closely mimic the characteristics and development of human MI are essential for better understanding the pathophysiology of heart failure and for developing medical or surgical therapies. Many of these models entail a surgical ligation of the coronary artery (with or without reperfusion), which is a reasonably reproducible technique, with the caveat that it results in a HF pattern different from what is seen in humans [57]. Percutaneous intracoronary embolization of various materials more closely duplicates acute coronary syndromes caused by embolization of atherosclerosis debris or thrombosis in the coronary microcirculation. Furthermore, the minimally invasive nature of the procedure reduces surgical complications and maintains the integrity of anatomical structures, particularly the pericardium which is involved in the regulation of myocardial inflammation and remodeling [6, 813]. However, the embolization technique also has limitations. First, it may be challenging to precisely control the location and duration of the coronary artery occlusion. Second, so far, it has been primarily applied to large animals (specifically pig and sheep). In an attempt to find an acceptable trade-off between rodent models, whose cardiac physiology is far from that of humans [14], and large animal models, which raise logistical and economic issues, the present study was designed to develop a straightforward and reproducible model of percutaneously induced MI in rabbits.

2. Materials and Methods

2.1. Animals

This study was approved by the University of Paris René Descartes Ethics Committee and by the ad hoc board of the French Ministry of Research and Education. Animals were cared for in accordance with the Guide for the Care and Use of Laboratory Animals [15].

2.2. Experimental Design

Adult male White New Zealand rabbits weighing 3.8–4.4 kg were used in this study. During the procedure, animals were anaesthetised using 5 mg/kg ketamine-HCl and 20 mg/kg propofol via the ear vein and anticoagulated with heparin (300 IU/kg). An antiarrhythmic protocol was implemented, which included beta-blockers/amiodarone and lidocaine (1 mg/kg load followed by a 20 μg/kg/min infusion) to reduce ischemic ventricular arrhythmias. Electrocardiogram and peripheral oxygen saturation were continuously recorded. Procedure success was assessed by the demonstration of a widening of the QRS complex or of ST segment elevation in the electrocardiogram and by TIMI 0 or 1 angiographic blood flow grades. After induction of MI, animals were kept under clinical observation. Animals with postprocedural heart failure received furosemide at 0.3 mg/kg/d for 3 days. After 3 weeks, animals were sedated as described above, examined clinically and echographically, and sacrificed. End points included impairment of left ventricular (LV) function at 3 weeks after procedure (by echocardiography using the Simpson method) and histologically confirmed myocardial infarction.

2.3. Experimental Procedures

Three series of experiments were sequentially performed.(1)Assessment of vascular access and coronary catheterization procedures: after having selected the right carotid artery as the vascular access entry site, 3 rabbits were used to test two devices (cathlons and fine needles); 2 animals were used for vessel catheterization and to select the optimal introducer sheath size. Four additional rabbits were then used for selecting the type and size of the guiding catheter for coronary catheterization and to determine the dilution of the contrast medium.(2)Assessment of the coronary occlusion site: to determine the coronary artery branch most suitable for occlusion to induce a functionally relevant MI, 14 rabbits underwent release of free and droppable coils. They were divided into three groups according to the target territory: the left descending artery area (), the circumflex artery territory (), or the right coronary artery territory (). After three weeks, sedated animals were evaluated clinically and echographically, according to the protocol described above, before being sacrificed and studied histologically.(3)Comparison of MI-inducing techniques: five different techniques of coronary occlusion were finally investigated: free coils (), interlocking coils (), balloon occlusion (), release of a thrombogenic sponge (), and injection of alcohol ().

For coils, a guiding catheter was positioned under fluoroscopic guidance at the coronary ostium and a 0.014-in. floppy wire was advanced into the coronary vessel. The wire was advanced into the dominant coronary artery branch, as determined by angiography (Figure 3). Over the wire, a microcatheter (FineCross MG, Terumo Corporation, Tokyo, Japan) was tracked into the coronary artery. Free coils were loaded into the microcatheter and dropped to the desired site. For interlocking coils, the procedure was modified in that the microcatheter was tracked, the floppy wire was removed, and the interlocking coil was loaded into the inner lumen of the microcatheter. It was then advanced to the optimal site and deployed. If interlocking coils failed to deploy, they could be removed. For balloon occlusion, an angioplasty balloon was tracked over the wire, placed into the target vessel, and inflated to occlude it. The desired period of occlusion was 300 seconds. In the thrombogenic sponge-injected group, a collagen sponge (Gelfoam, Pfizer, New York, NY, USA) was cut according to the size of the target vessel, impregnated with a contrast solution and dropped through the microcatheter. For alcohol injection, the microcatheter had to be positioned so as to occlude the coronary artery. When a lack of retrograde flow was confirmed by angiography, the alcohol was injected into the microcatheter. Because of insufficient selectivity, we used a coaxial total chronic coronary occlusion balloon catheter as a microcatheter to achieve a superselective injection of 0.2 mL of alcohol (Mini-Trek, Abbott, Chicago, IL, USA). This device offers a better crossing profile and a better push. After removal of the 0.014-in. floppy wire, contrast medium was injected into the inner lumen of the balloon to verify vascular occlusion. Alcohol was then injected into the target artery to induce necrosis of the adjacent tissue and hence induce an infarction.

2.4. Histological Examination

Hearts in which a myocardial infarct was macroscopically observed at autopsy underwent a histological analysis (Figures 1 and 2). Hearts were excised, cut in the coronal plane into three sections from apex to base, embedded in OCT, flash-frozen in liquid nitrogen, and stored at −80°C. Ten-micrometer cryosections were stained with hematoxylin-eosin to confirm the presence of ischemic tissue.

2.5. Echocardiography

In vivo heart function was evaluated by echocardiography three weeks after ischemic injury. Transthoracic echocardiography was performed on sedated animals by an experienced cardiologist using an echocardiography machine equipped with an appropriate probe for imaging rabbit hearts (Vivid E9 ultrasound platform, GE Health Care, Pittsburgh, PA, USA). Two-dimensional mages were taken using both long axis and short axis views. Measurements were taken to evaluate the following parameters: dimensions of the LV, left atrium, wall thickness, valve function, and LV ejection fraction (calculated using Simpson’s method).

2.6. Statistical Analysis

Data are given in percentages and means ± standard deviations. Comparisons between groups were made using the nonparametric ANOVA test for continuous variables. A value was considered statistically significant. Statistical analysis was performed with JMP 9.1 software (SAS, Cary, NC, USA).

3. Results

3.1. Assessment of Vascular Access and Coronary Catheterization Procedures

The safest micropuncture vascular access was achieved using needles and 0.018-in. wires. A 4-Fr micropuncture sheath was effective. It was advanced over the wire and exchanged for a 0.035-in. guidewire to support the placement of a 4-Fr internal mammary guide catheter (Cordis Corporation, Miami, FL, USA), with custom alteration for use in a rabbit. The guiding catheter was advanced retrogradely to the ascending aorta using fluoroscopy, and an angiography of the coronary artery was then performed to check for its adequate location. Dilution of the contrast medium was kept at 50% of the total volume to reduce the risk of ventricular arrhythmias.

3.2. Assessment of the Coronary Occlusion Site

Middle or proximal segment occlusion of the left anterior descending coronary artery led to severe heart failure with massive hemorrhagic infarction of the LV, while distal segment occlusion caused severe conduction disturbances requiring isoprenaline infusion. The occlusion of the branches (diagonal and septal branches) needed a custom device and led to only small nontransmural infarcted areas, without a relevant decrease in LVEF. Occlusion of obtuse marginal branches yielded a very limited, nontransmural LV infarction without functional consequences, as assessed by echocardiography. Only occlusion either of the mid segment of the right coronary artery or of the mid segment of the circumflex coronary artery was finally found to be the most reliable procedure for inducing an extensive infarction of the supplied LV area. Such infarcts led to an akinesia/hypokinesia of the right ventricle and of the inferior wall of the left ventricle (right coronary occlusion or circumflex coronary occlusion, resp.) with, in both cases, a 25% decrease in LVEF and only nonsustained ventricular arrhythmias. These data (summarized in Table 1) led to the conclusion that, according to the coronary artery distribution, the dominant vessel would be the best target for embolization.


Embolization site
()
Intraoperative events3-week survival
()
Echographic assessmentHistologic assessment

LAD
 Proximal segment ()VF0Transmural infarct
 Mid segment ()VF0Transmural infarct
 Distal segment ()ACD0Transmural infarct
 S. branch vessel ()1No LV dysfunctionNontransmural infarct
CA
 Proximal segment ()NSVT, CHF0Transmural infarct
 Mid segment ()NSVT2LV dysfunctionTransmural infarct
 Distal segment ()
 S. branch vessel ()2No LV dysfunctionNontransmural infarct
RCA
 Proximal segment ()CHF0Transmural infarct
 Mid segment ()NSVT2LV and RV dysfunctionTransmural infarct
 Distal segment ()

LAD: left anterior descending; CA: circumflex artery; RCA: right coronary artery; LV: left ventricle; RV: right ventricle; VF: ventricular fibrillation; ACD: atrioventricular conduction disorder; NSVT: nonsustained ventricular tachycardia; CHF: congestive heart failure; S. branch vessel: secondary branch vessel.
3.3. Comparison of MI-Inducing Techniques
3.3.1. Free Coil Embolization

Four rabbits underwent free coil embolization. Two coils deployed at the left main artery ostium and protruded into the aorta. One coil deployed at the circumflex artery proximal segment and one deployed at the right coronary artery ostium. All of these rabbits died from intraoperative refractory ventricular fibrillation. Histological examination revealed large left and right ventricle hemorrhagic necrosis, depending on the occlusion site (Tables 2 and 3).


Embolization device
()
Intraoperative events3-week survival
()
Echographic assessmentHistologic assessment

Free coil
 CA ()VF0Transmural infarct
 RCA ()VF0Transmural infarct
Interlocking coil
 CA ()VF1LVEF decrease <15%Nontransmural infarct
 RCA ()VF1No dysfunctionNo infarct
Gelatin sponge
 CA ()3No dysfunctionNontransmural infarct
 RCA ()1No dysfunctionNo infarct
Balloon occlusion
 CA ()NSVT2No dysfunctionNo infarct
 RCA ()NSVT2No dysfunctionNo infarct
Alcoholization
 CA ()VF415% decrease in LVEFTransmural infarct
 RCA ()CHF2RV dysfunction
15% decrease in LVEF
Transmural infarct

CA: circumflex artery; RCA: right coronary artery; LV: left ventricle; RV: right ventricle; VF: ventricular fibrillation; NSVT: nonsustained ventricular tachycardia; CHF: congestive heart failure.

Before embolisationAfter embolisationProb. >

DIVS (mm)3.8 ± 0.24.0 ± 0.22,3540,155
DLVID (mm)17.4 ± 0.420.1 ± 1.129,236<0,001
DLVPW (mm)5.5 ± 0.25.5 ± 0.30,0520,823
SIV (mm)4.1 ± 0.24.1 ± 0.20,2200,648
SLVID (mm)12.1 ± 0.516.5 ± 0.9104,824<0,001
SLVPW (mm)5.7 ± 0.25.7 ± 0.20,0180,894
LVEF (Teichholz (%))58.0 ± 2.943.5 ± 1.6113,648<0,001
FS (%)30.5 ± 1.818.0 ± 0.9240,384<0,001
LVESV (mL)2.9 ± 0.23.4 ± 0.119,7360,001
LVEDV (mL)1.2 ± 0.21.8 ± 0.237,097<0,001
LVEF (biplane Simpson (%))58.3 ± 2.647.0 ± 2.460,8421<0,001
SV (mL)1.7 ± 0.21.6 ± 0.21,6800,223

DIVS: diastolic interventricular septum; DLVID: diastolic left ventricle inner diameter; DLVPW: diastolic left ventricle posterior wall; SIVS: systolic interventricular septum; SLVID: systolic left ventricle inner diameter; SLVPW: systolic left ventricle posterior wall; LVEF: left ventricle ejection fraction; FS: fractional shortening; LVESV: left ventricle end systolic volume; LVEDV: left ventricle end diastolic volume; SV: stroke volume.
3.3.2. Interlocking Coil Embolization

Four rabbits underwent interlocking coil embolization in the mid segment of the target coronary artery. Two animals died from intraoperative refractory ventricular fibrillation during coil deployment in the circumflex and right coronary arteries, possibly due to the unwanted occlusion of the more proximal arterial segment due to excessively long coils. Two animals survived the procedure and until the end of the study. In both of these cases, the coils were too short, causing their migration towards the distality of the target vessel (the circumflex artery in one case and the right coronary artery in the other). Expectedly, this resulted in limited nontransmural or even undetectable infarct areas without changes in LVEF (Tables 2 and 3).

3.3.3. Gelatin Sponge Embolization

Gelatin sponges were used in four procedures (three right coronary artery mid segment embolization and one circumflex mid segment embolization). No intraoperative or postoperative arrhythmias occurred and all animals survived until the end of the study. The likely reason was that only histologically limited nontransmural LV lateral wall infarcts were detectable after circumflex embolization while no myocardial damage could be identified in the case of right coronary artery embolization. No LVEF decrease could be echographically detected in any of these cases (Figure 4; Tables 2 and 3).

3.3.4. Balloon Occlusion

Four animals underwent balloon occlusion, of the right coronary mid segment (two cases) and of the circumflex mid segment (two remaining cases). All animals survived despite the occurrence of nonsustained ventricular tachycardia which resolved after balloon deflation. Both echocardiographic and histological examinations failed to reveal any cardiac abnormality (Tables 2 and 3).

3.3.5. Alcohol Injection

Eight animals underwent alcohol injection in the mid segment of the right coronary artery and of the circumflex artery in five and three cases, respectively. All angiograms performed after alcohol injection showed coronary artery TIMI flow 0 or I and a pattern of myography in the infarcted area. One animal with circumflex artery alcoholization died from refractory ventricular fibrillation. Another rabbit which had undergone alcohol injection in the right coronary artery died two days after surgery from drug-refractory heart failure. However, the 6 remaining rabbits survived until the end of the study. Four of them were then found to have a macroscopically massive infarction of the right ventricle and of the LV inferior wall, which was confirmed by histological analysis. Two other rabbits had massive infarction of the left ventricle lateral wall. In all of these survivors, LVEF was significantly reduced from its baseline value (19,4 ± 2,4%; Tables 2 and 3).

4. Discussion

It is generally accepted that proof-of-concept studies designed to test the efficacy of new drug-, cell-, or other biologics-based therapies for HF can be reliably performed in rat and mouse [16, 17]. However, the drawbacks of these rodent models are also well recognized. They primarily include major differences in heart physiology compared with humans and a limited lifespan which precludes long-term follow-up assessments. These hurdles can be overcome by the use of large animal models, primarily pig and sheep, which offer distinct advantages: a more clinically relevant cardiac physiology, a size allowing testing catheter-based delivery devices, and the possibility of realistically studying dose-effect relationships [14, 18, 19]. However, these models are more logistically complex and costly as they require dedicated facilities and highly trained personnel. In this setting, the rabbit appears as an attractive trade-off. The physiology of this species is not so far from that of humans with regard to heart rate and patterns of contractility-related calcium handling and myosin heavy chain isoforms, while vessels size is compatible with the testing of catheter-based interventions [20, 21]. Indeed, several studies have used a rabbit model of MI induced by permanent or transient coronary artery ligation, but, in most cases the procedure has been performed through a direct surgical approach of the target artery [22]. Closed-chest procedures have been less commonly reported despite distinct advantages such as a limited invasiveness and the possibility of keeping the pericardium untouched and free from adhesions. The latter avoids the confounding effect of pericardial incision on postinfarction remodeling. This model also allows, when indicated, a subsequent direct intramyocardial delivery of the product under investigation [5, 23]. The recognition of these advantages prompted the present study which entailed the first angiography-based characterization of the coronary artery anatomical patterns in rabbits and the development of a reproducible percutaneous catheter-based technique of myocardial necrosis induction.

Our review of the angiograms that we performed in our initial series of 14 rabbits did not yield results which matched those previously published [24, 25]. Basically, the coronary artery anatomy of the rabbit seems to be organized as in humans with a constant left main coronary artery and left or right coronary artery dominance depending on whether the posterior descending artery originates from the circumflex coronary artery or the right coronary artery, respectively. The left main artery divides into the left anterior descending (LAD) and the circumflex arteries. The LAD travels in the anterior interventricular groove and continues up to the apex of the heart. It supplies the anterior part of the septum with septal branches and the anterior wall of the left ventricle with diagonal branches. The circumflex and right coronary arteries supply the lateral wall of the left and right ventricle, respectively.

Given this configuration, embolization of secondary branches of epicardial vessels such as marginal, septal, and diagonal branches only resulted in functionally inconsequent infarctions at the cost of complicated procedures while, contrariwise, embolization of the LAD was associated with much too extensive myocardial damage. We thus elected to focus on the dominant vessel; however the high sensitivity of the rabbit to ischemia required carefully controlling the level of its occlusion to ensure a substantial impairment of LV function, but with an acceptable mortality rate. Targeting a decrease in LVEF of 20% from baseline targeting was found to be a reasonable objective which could then be reproducibly achieved by locating the occlusion site at the mid segment of either the right coronary or the circumflex coronary artery.

These screening experiments then set the stage for the comparison of different infarction-inducing techniques which, to our knowledge, have not yet been reported. So far, the few studies which have used a closed-chest approach for inducing MI in rabbits have relied on the use of coils [5, 23]. We thus started our experiments with this type of material but, in our hands, neither free nor interlocking coils could generate reproducible results. It was difficult to load free coils into the delivery catheter and to control the exact site, timing, and extent of their deployment in the target artery and it was equally challenging to release interlocking coils in such a way as to occlude to coronary resulting in a substantial impairment of LV function that was still compatible with survival of the rabbit. The high cost of coils is another limiting factor. Both the release of gelatin sponge and the balloon inflation then looked initially attractive because of their purported simplicity. Indeed, gelatin sponge was plastic enough to yield an excellent conformability within the catheter but featured several disadvantages such as difficult handling, adherence to the catheter inner lumen, and poor visualization under fluoroscopy. Balloon-induced vessel occlusions, in turn, were arrhythmogenic unless inflations were kept short, in which case large infarcts could not be generated. Inspired by alcohol septal ablation performed in patients with hypertrophic obstructive cardiomyopathy, we finally tested alcohol injection. In contrast to the other techniques, alcohol injection allowed assessment of the TIMI flow grade just after the injection without removing the device. Because of the lack of selective injections, the first attempts performed with the microcatheter resulted in massive infarction. Optimized injections were then made possible using a coaxial total chronic occlusion balloon catheter as the microcatheter to achieve a superselective injection of 0.2 mL of alcohol. Considering both the amount of pathologically damaged myocardium, the resulting loss of echocardiographically measured pump function, and the survival of animals, this technique proved to offer the best risk to benefit ratio.

We acknowledge several limitations of the present study. Coils which were tested were those commercially available and we cannot exclude that customizing these devices would not have resulted in better outcomes. Second, functional assessments only consisted of gross measurements of EF and a more detailed analysis of the patterns of regional contraction and relaxation is clearly required to better characterize the hemodynamic effects of any coronary artery occlusion technique. Finally, the damage induced by alcohol injection may not accurately model that seen in patients with ischemic heart disease, although alcohol injection was found to depress LV function to a sufficient extent as to give room for detecting treatment effects for testing interventions. Despite these caveats, the present data can provide a useful benchmark for improving catheter-based techniques of coronary artery occlusion in rabbits and facilitate a broader use of this model for testing drugs or interventions designed to mitigate the consequences of ischemically induced LV dysfunction.

5. Conclusion

By following a stepwise approach, a minimally invasive, effective, and reproducible rabbit model of catheter-induced myocardial infarction has been developed which addresses the limitations of rodent experiments while avoiding the logistical and cost issues associated with large animal models.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. V. L. Roger, “Epidemiology of heart failure,” Circulation Research, vol. 113, no. 6, pp. 646–659, 2013. View at: Publisher Site | Google Scholar
  2. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association,” Circulation, vol. 127, no. 1, pp. 143–152, 2013. View at: Publisher Site | Google Scholar
  3. R. S.-Y. Foo, K. Mani, and R. N. Kitsis, “Death begets failure in the heart,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 565–571, 2005. View at: Publisher Site | Google Scholar
  4. M. Chiong, Z. V. Wang, Z. Pedrozo et al., “Cardiomyocyte death: mechanisms and translational implications,” Cell Death & Disease, vol. 22, no. 2, pp. 222–244, 2011. View at: Google Scholar
  5. R. Edwards, Z. Yousef, R. Rakhit et al., “A model of closed chest regional myocardial infarction in the rabbit: a clinically relevant in vivo assay system of post-infarction remodelling,” Basic Research in Cardiology, vol. 97, no. 5, pp. 374–383, 2002. View at: Publisher Site | Google Scholar
  6. R. Klocke, W. Tian, M. T. Kuhlmann, and S. Nikol, “Surgical animal models of heart failure related to coronary heart disease,” Cardiovascular Research, vol. 74, no. 1, pp. 29–38, 2007. View at: Publisher Site | Google Scholar
  7. A. M. Abarbanell, J. L. Herrmann, B. R. Weil et al., “Animal models of myocardial and vascular injury,” Journal of Surgical Research, vol. 162, no. 2, pp. 239–249, 2010. View at: Publisher Site | Google Scholar
  8. D. H. Spodick, The Pericardium: A Comprehensive Textbook, edited by: D. H. Spodick, CRC Press, New York, NY, USA, 1996.
  9. D. Hasdai, V. Barak, E. Leibovitz et al., “Serum basic fibroblast growth factor levels in patients with ischemic heart disease,” International Journal of Cardiology, vol. 59, no. 2, pp. 133–138, 1997. View at: Publisher Site | Google Scholar
  10. M. Fujita, M. Ikemoto, M. Kishishita et al., “Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina,” Circulation, vol. 94, no. 4, pp. 610–613, 1996. View at: Publisher Site | Google Scholar
  11. S. Corda, A. Mebazaa, M.-P. Gandolfini et al., “Trophic effect of human pericardial fluid on adult cardiac myocytes: differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy,” Circulation Research, vol. 81, no. 5, pp. 679–687, 1997. View at: Publisher Site | Google Scholar
  12. B. Schumacher, P. Peecher, B. U. von Specht, and T. Stegmann, “Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease,” Circulation, vol. 97, no. 7, pp. 645–650, 1998. View at: Publisher Site | Google Scholar
  13. C. Landau, A. K. Jacobs, and C. C. Haudenschild, “Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia,” American Heart Journal, vol. 129, no. 5, pp. 924–931, 1995. View at: Publisher Site | Google Scholar
  14. A. Halapas, A. Papalois, A. Stauropoulou et al., “In vivo models for heart failure research,” In Vivo, vol. 22, no. 6, pp. 767–780, 2008. View at: Google Scholar
  15. National Research Council (US) Institute for Laboratory Animal Research, Guide for the Care and Use of Laboratory Animals, National Academies Press (US), Washington, DC, USA, 1996.
  16. R. J. Figueroa, T. G. Koch, and D. H. Betts, Stem Cells and Animal Therapies, edited by M. Moo-Young, 2011.
  17. N. Milani-Nejad and P. M. L. Janssen, “Small and large animal models in cardiac contraction research: advantages and disadvantages,” Pharmacology and Therapeutics, vol. 141, no. 3, pp. 235–249, 2014. View at: Publisher Site | Google Scholar
  18. C. A. Muller, L. H. Opie, C. A. Pineda, and M. Peisach, “Bucindolol, a beta blocker, decreased ventricular fibrillation and maintained mechanical function in a pig model of acute myocardial ischemia,” Cardiovascular Drugs and Therapy, vol. 6, no. 3, pp. 233–237, 1992. View at: Publisher Site | Google Scholar
  19. H. N. Sabbah, P. D. Stein, T. Kono et al., “A canine model of chronic heart failure produced by multiple sequential coronary microembolizations,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 260, no. 4, pp. H1379–H1384, 1991. View at: Google Scholar
  20. V. Piacentino III, C. R. Weber, X. Chen et al., “Cellular basis of abnormal calcium transients of failing human ventricular myocytes,” Circulation Research, vol. 92, no. 6, pp. 651–658, 2003. View at: Publisher Site | Google Scholar
  21. T. Suzuki, B. M. Palmer, J. James et al., “Effects of cardiac myosin isoform variation on myofilament function and crossbridge kinetics in transgenic rabbits,” Circulation: Heart Failure, vol. 2, no. 4, pp. 334–341, 2009. View at: Publisher Site | Google Scholar
  22. K. W. Mahaffey, T. E. Raya, G. D. Pennock, E. Morkin, and S. Goldman, “Left ventricular performance and remodeling in rabbits after myocardial infarction: effects of a thyroid hormone analogue,” Circulation, vol. 91, no. 3, pp. 794–802, 1995. View at: Publisher Site | Google Scholar
  23. O. Ziv, L. Schofield, E. Lau et al., “A novel, minimally invasive, segmental myocardial infarction with a clear healed infarct borderzone in rabbits,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 11, pp. H2321–H2330, 2012. View at: Publisher Site | Google Scholar
  24. B. Podesser, G. Wollenek, R. Seitelberger et al., “Epicardial branches of the coronary arteries and their distribution in the rabbit heart: the rabbit heart as a model of regional ischemia,” The Anatomical Record, vol. 247, no. 4, pp. 521–527, 1997. View at: Publisher Site | Google Scholar
  25. T. A. Pearson, H. Malmros, J. Dillman, N. Sternby, and R. H. Heptinstall, “Atherosclerosis in the hypercholesterolemic hare. Comparison of coronary artery lesions induced by dietary cholesterol in the hare and the rabbit,” Atherosclerosis, vol. 63, no. 2-3, pp. 125–135, 1987. View at: Publisher Site | Google Scholar

Copyright © 2015 Marc-Antoine Isorni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1334 Views | 780 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.